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With the rates of obesity remaining high, health risks are abundant. This includes 
an increased possibility of the development of insulin resistance and type 2 diabetes 
mellitus (T2DM).  Several biochemical and histochemical characteristics associated with 
obesity have been reported, including a reduction in capillary density in the skeletal 
muscle and increased muscle fiber size. Resistance exercise is known to induce 
hypertrophy and increase skeletal muscle capillarization. Following acute resistance 
exercise, it is hypothesized angiogenic factors are reduced and angiostatic factors are 
increased in the skeletal muscle of obese individuals. Muscle biopsies from the vastus 
lateralis were obtained to investigate whether VEGF, VEGF receptor, TSP-1 expression, 
and AMPK phosphorylation (an indicator AMPK activation) are lower in obese 
compared to lean individuals at rest and in response to an acute bout of exercise. Muscle 
biopsies were taken before, 15 MIN, and 3 HR following 3 sets of single-leg knee 
extension at 80% 1 RM. Eight sedentary lean (4 male, 4 female) and eight sedentary 
obese (4 male, 4 female) individuals participated in this study. No differences in VEGF 
or VEGF receptor mRNA and protein levels were found at rest or following exercise in 
lean or obese individuals. Exercise increased VEGF mRNA independent of group. 






phosphorylation and no differences between lean and obese were found. The present 
study suggests that the angiogenic response to resistance exercise (a known hypertrophic 





CHAPTER 1. INTRODUCTION 
 Obesity and Insulin Resistance 
The prevalence of obesity in the United States remains high, with 78.6 million 
adults currently falling under this classification (Centers for Disease Control and 
Prevention, 2014). Many chronic conditions are associated with obesity, which has 
earned it the title of the second leading cause of preventable death in the United States by 
the National Heart, Lung, and Blood Institute (NHLBI). Health problems associated with 
obesity include hypertension, heart disease, metabolic syndrome, and type 2 diabetes 
mellitus (T2DM) (Mayo Clinic, 2015). In 2008, the estimated annual medical cost of 
obesity in the United States was $147 billion and has been projected to rise due to the 
increasing prevalence of T2DM (Centers for Disease Control and Prevention, 2014). 
According to the National Institute of Diabetes and Digestive and Kidney Diseases 
(NIDDK), T2DM frequently is the result of prolonged insulin resistance or a decreased 
sensitivity and/or responsiveness to insulin. Insulin resistance is common among the 
obese population. It is estimated that 24% of obese adults in the United States are insulin 
resistant while in the obese adolescent population prevalence is estimated at 52% (Lee et 
al, 2006; McKeown et al, 2004).  
The human body consists of roughly 40% skeletal muscle, which is responsible 





Several biochemical and histochemical characteristics within the skeletal muscle have 
been associated with obesity. Studies have shown fiber type dissimilarities between the 
skeletal muscles of lean compared to obese individuals. A decrease in Type I, slow twitch 
oxidative, fibers concurrent with an increase in Type IIB, fast twitch glycolytic, fibers has 
been noted in obese individuals (Lillioja et al, 1987). The area of skeletal muscle fibers of 
obese individuals is significantly larger than the skeletal muscle fibers of lean individuals 
(Gavin et al, 2005). Reduced mitochondrial function, reducing the oxidative capacity of 
the skeletal muscle, has also been reported in obese individuals (Torgan et al, 1989). 
Primarily, obesity has been strongly correlated to a reduction in capillary density, or the 
number of capillaries per unit cross-sectional area of muscle (Gavin et al, 2005; Lash et 
al, 1989; Lillioja et al, 1987; Shono et al, 1999; Torgan et al, 1989).  Capillaries are 
essential for the delivery of oxygen and other nutrients important for energy production. 
Increased capillarization ensures adequate diffusion capacity across the skeletal muscle 
(Hudlicka, Brown & Egginton, 1992). Therefore, alterations in skeletal muscle 
capillarization may contribute to much of the insulin resistance associated with obesity 
(Lillioja et al, 1987; Shono et al, 1999). 
 
 The Impact of Exercise 
Exercise has been proven to be beneficial to overall health in a variety of ways. 
Those who participate in physical activity for 7 hours or more a week reduce their risk of 
mortality by 40% (Centers for Disease Control and Prevention, 2015). It has been well-
established that endurance training provides many improvements to overall health. A host 





muscle changes. Adaptations in skeletal muscle include increases in mitochondrial 
content, respiratory capacity, and capillary density of muscle fibers (Andersen & 
Henriksson, 1977; Hermansen & Wachtlova, 1971; Holloszy & Coyle, 1984; Yamashita 
et al, 1993). Regular resistance exercise can also improve cardiovascular, bone, and 
muscle health and reduce the risks of many chronic diseases (American College of Sports 
Medicine Position Stand, 1990). Muscle hypertrophy observed with resistance exercise 
contributes to an increase in muscle strength, basal metabolic rate, and lean body mass, 
while decreasing body fat composition. Resistance exercise has also been shown to 
benefit glucose metabolism, lowering basal insulin levels and increasing insulin 
sensitivity (Pollock & Vincent, 1996). Less recognized as an outcome of resistance 
exercise is an increase in skeletal muscle capillarization (McCall et al, 1996; Schantz, 
1982). Increased capillary density improves the exchange of oxygen, substrates, and 
metabolites between blood and skeletal muscle (Andersen & Henriksson, 1977; 
Hermansen & Wachtlova, 1971; Poole, Copp, Ferguson, & Musch, 2013; Tesch, 
Thorsson & Kaiser, 1984), which is vitally important for individuals with chronic 
conditions where this exchange has been compromised (Adair & Montani, 2010). 
 
 Skeletal Muscle Angiogenesis 
Angiogenesis, the process of generating new capillary blood vessels, occurs in 
response to signals from changes in mechanical stimuli and metabolic demand (Hudlicka, 
Brown & Egginton, 1992). It involves a complex cascade of events leading to the 





The interplay of both angiogenic (positive) and angiostatic (negative) factors contribute 
to this process. 
Angiogenic and Angiostatic Factors 
 One of the most vital pro-angiogenic factors for basal and exercise-induced 
capillarization is vascular endothelial growth factor (VEGF). VEGF is a 45 kDa heparin-
binding vascular EC mitogen of the micro- and macrovascular EC of arteries, veins, and 
the lymphatics (Amaral et al, 2001; Dvorak et al, 1979; Ferrara & Davis-Smyth, 1997; 
Ferrara & Henzel, 1989; Gavin TP, 2009; Olfert et al, 2009; Tang et al, 2004; Wagner et 
al, 2006). Although several different isoforms exists, VEGF-A plays the most crucial role 
in exercise-induced skeletal muscle angiogenesis (Shweiki et al, 1992; Waltenberger et 
al, 1994). It is released into the muscle interstitial space in response to mechanical stimuli  
and other stress inducing factors (Gavin et al, 2007; Hoffner, Nielsen, Langberg, & 
Hellsten, 2003; Hoier et al, 2011; Hoier et al, 2012; Hoier et al, 2010; Ouchi, Shibata, & 
Walsh, 2005), including hypoxia, oxidative stress, growth factors, and cytokines (Ikeda et 
al, 1995; Kuroki et al, 1996; Takahashi et al, 2002; Wang, Huang, Kazlauskas, & 
Cavenee, 1999).  
Two receptors identified as having a high affinity for VEGF are VEGFR1 (de Vries 
et al, 1992) and VEGFR2. Expression of both receptors is restricted to the vascular 
endothelium, where the positive charge of the surface of VEGF facilitates its binding 
(Ferrara & Keyt, 1997; Keyt et al, 1996; Yamaguchi et al, 1993). VEGFR2 is suggested 
to be the receptor principally involved in angiogenesis (Millauer et al, 1993; Gavin TP, 
2009; Waltenberger et al, 1994). The phosphorylation of VEGFR2 initiates several 





proliferation, and survival of EC (Connolly et al, 1989; Koch et al, 2011). One important 
cascade involves VEGFR2 activation of endothelial nitric oxide synthase (eNOS) to 
produce nitric oxide (NO) which in turn stimulates EC growth and motility (Ziche et al, 
1994). The NO cascade activated by VEGFR2 phosphorylation is inhibited by 
thrombospondin-1 (TSP-1) (Isenberg et al, 2006). 
TSP-1 is a 450 kDa multifunctional homotrimeric matrix glycoprotein that is 
thought to play an important role in the regulation of angiogenesis (Iruela-Arispe et al, 
1995; Lawler, Slayter, & Coligan, 1978). Though TSP-1 has been shown to stimulate the 
growth and migration of smooth muscle cells (BenEzra, Griffin, Maftzir, & Aharonov, 
1993; Lawler, 2000; Nicosia & Tuszynski, 1994). It prevents angiogenesis via inhibition 
of VEGF release, VEGF signal transduction, and by direct interaction with VEGF 
(Iruela-Arispe, Bornstein, & Sage, 1991; Lawler & Lawler, 2012). VEGF bioavailability 
is decreased due to the influence of TSP-1 on the structure of the extracellular matrix 
(Iruela-Arispe et al, 1995; Lawler, 1986; Chen, Herndon, & Lawler, 2000). TSP-1 
binding to receptors CD36 and CD47 inhibits VEGFR2 phosphorylation (Primo et al, 
2005), which hinders EC association at the site of development (Bagavandoss & ilks, 
1990; Dawson et al, 1997), migration of EC, and stimulates apoptosis (Iruela-Arispe, 
Bornstein, & Sage, 1991). Further, the uptake and clearance of VEGF from the 
extracellular space is induced by TSP-1 binding directly to VEGF (Gupta et al, 1999; 
Greenaway et al, 2007; Lawler & Lawler, 2012). Consistent with TSP-1 being an 
angiostatic factor, skeletal muscle capillarization is lower in TSP-1 knock-out (KO) 






A key player in the regulation of the responses to angiogenesis-inducing stressors is 
the heterotrimeric enzyme 5’-AMP-activated protein kinase (AMPK) (Hardie, 2003). 
When two molecules of adenosine diphosphate (ADP) are used to produce energy in the 
form of adenosine triphosphate (ATP), the result is the production of one molecule of 
adenosine monophosphate (AMP) (Kalckar, 1943). In order for a cell to maintain a 
necessary level of energy for proper function, the ratio of ATP to AMP must remain high. 
When reductions in the ratio occur, AMPK is activated. Reduced ATP:AMP is caused by 
disruptions in the production of ATP, hypoxia or ischemia, and/or increases in the 
consumption of ATP through muscle contraction (Kudo et al, 1995; Marsin et al, 2000; 
Winder & Hardie, 1996). The phosphorylation of upstream kinases induces AMPK to 
regulate cellular energy usage (Hawley et al, 1995). AMP regulates the activation of 
AMPK and inhibits AMPK dephosphorylation by protein phosphatases (Hawley et al, 
1995).  
The activation of AMPK stimulates energy-conserving/producing pathways to 
increase while simultaneously decreasing energy-consuming pathways. Previous research 
suggests AMPK regulates VEGF in the skeletal muscle through the activation of p38 
mitogen-activated protein kinase (MAPK) (Pages et al, 2000; Ouchi, Shibata, & Walsh, 
2005; Winzen et al, 1999). AMPK also plays a role in the mediation of NO activity (Zhu 
& Smart, 2005).  Increased AMPK activity has been shown to increase VEGF mRNA 
and VEGF protein, thereby increasing capillarization and the inactivation of AMPK 
reduces capillarization at the basal level (Ouchi et al, 2005; Zwetsloot, Westerkamp, 





exercise-induced angiogenesis, but may play a role in response to resistance exercise 
(Zwetsloot, Westerkamp, Holmes & Gavin, 2008).  
 
Figure 1: Angiogenic Pathway in Response to Exercise.1Ouchi, Shibata & Walsh, 2005-
will not be investigated in this report 2Ziche et al, 1994; Isenberg et al, 2006-will not be 
investigated in this report 
 
 
 Obesity  
 The skeletal muscle fiber size of obese individuals is markedly increased 
compared to their lean counterparts (Gavin et al, 2005). VEGF is a necessary component 
for muscle hypertrophy (Huey, Smith, Sulaeman & Breen, 2016), and basal regulation of 
skeletal muscle VEGF and capillarization is altered by resting levels of AMPK 
(Zwetsloot, Westerkamp, Holmes, & Gavin, 2008). However, resting levels of metabolic 
and regulatory factors of angiogenesis are similar between lean and obese individuals of 
similar physical inactivity. No differences at rest in AMPK, VEGF, or VEGFR2 
expression have been found despite reduced capillary density and muscle fiber 
hypertrophy observed in obese subjects (Gavin et al, 2005; Steinberg et al, 2004). Though 
comparisons of basal TSP-1 in the skeletal muscle of lean and obese have not been 





increased circulating TSP-1 in obese subjects has been noted (Abu-Farha, 2013; Hida et 
al, 2000; Inoue et al, 2013; Varma et al, 2008; Voros et al, 2005). 
 
  Exercise and Angiogenesis  
Aerobic Exercise 
 Angiogenesis in response to aerobic exercise in lean subjects has been well 
researched. The interplay of angiogenic and angiostatic factors lead to an increase in 
capillary density of the skeletal muscle following endurance training (Andersen & 
Henriksson, 1977). Studies consistently report elevations in VEGF and VEGFR2 
expression in the skeletal muscle in response to acute endurance exercise (Benoit et al, 
1999; Gavin et al, 2005; Gustafsson et al, 2005; Ryan et al, 2006). Furthermore, TSP-1 is 
temporarily increased following acute aerobic exercise, appearing to modulate capillary 
formation (Hoier et al, 2012; Olfert et al, 2006; Olfert, Wagner, & Power, 2000). Cellular 
energy usage is regulated through an increase of AMPK activity, heavily dependent upon 
the duration and intensity of the exercise session (Fujii et al, 2000; Rasmussen & Winder, 
1997; Stephens et al, 2002; Winder & Hardie, 1996; Wojtaszewski et al, 2000). AMPK is 
not a necessary part of the angiogenic response to aerobic exercise (Zwetsloot, 
Westerkamp, Holmes, & Gavin, 2008) but is one potential regulator of VEGF expression, 
a key component for the muscle hypertrophic response to resistance exercise (Huey, 
Smith, Sulaeman & Breen, 2016). 
Resistance Exercise 
There is very little research regarding the skeletal muscle angiogenic response 





capillarization in the skeletal muscle in lean subjects (McCall et al, 1996; Schantz, 1982). 
The increased capillarization is in proportion to the hypertrophy of the muscle fibers in 
order to maintain the capillary density of the skeletal muscle (McCall et al, 1996; 
Schantz, 1982). The angiogenic response to resistance exercise in terms of VEGF and 
VEGFR2 expression is similar to that seen following aerobic exercise (Doyle & Haas, 
2010; Huey, Smith, Sulaeman & Breen, 2016; Degens, Moore, & Alway, 2003; Gavin et 
al, 2007; Parvaresh et al, 2010). Increases in VEGF mRNA are observed 2-3 h post 
resistance exercise (Gavin et al, 2007; Silvennoinen et al, 2015) and VEGFR2 mRNA 4 h 
post resistance exercise (Gavin et al, 2007). These increases in VEGF and VEGFR2 
expression has been shown to play important roles in the maintenance of capillarization, 
which is necessary for proper hypertrophy of the muscle (Huey, Smith, Sulaeman & 
Breen, 2016). Elevated AMPK activity has also been noted in lean individuals during and 
1 h following resistance exercise (Dreyer et al, 2006), indicating a potential role in 
regulating VEGF production following resistance exercise. No investigations into TSP-1 
expression in the skeletal muscle following resistance exercise have been published.  
 
 Obesity, Exercise, & Angiogenesis 
Although no differences reside in basal levels of angiogenic factors between lean 
and obese, obese demonstrate lower capillarization in the skeletal muscle (Gavin et al, 
2005). An important stimulator of the angiogenic process is exercise (McCall et al, 1996; 
Schantz, 1982). Few have reported any differences in the angiogenic response to aerobic 
exercise between lean and obese individuals (Gavin et al, 2005; Walton et al, 2015). 






AMPK activity following endurance exercise, suggesting an impaired response of AMPK 
to aerobic exercise (Sriwijitkamol et al, 2007). However, VEGF and VEGFR2 expression 
in response to aerobic exercise is similar between lean and obese individuals (Gavin et al, 
2005). Levels of TSP-1, a potent angiostatic factor, in the adipose tissue of obese 
individuals return to normal following acute exercise (Abu-Farha et al, 2013). 
Although the hypertrophic response to resistance training is evident in obese 
individuals (Donnelly et al, 1993; Geisler et al, 2011), researchers have not compared the 
skeletal muscle angiogenic response following resistance exercise in lean and obese 
individuals to date. The lack of differences in VEGF and VEGFR2 expression following 
aerobic exercise, combined with the increased fiber diameter with subsequent decreased 
capillarization (Gavin et al, 2005; McCall et al, 1996), suggests a decreased angiogenic 
response to muscle hypertrophy in the skeletal muscle of obese individuals. 
 
 Hypothesis 
At rest, obese subjects will have increased TSP-1 expression compared to lean 
counterparts. Following acute resistance exercise, obese subjects will have: (i) lower 
VEGF, VEGF receptor, and AMPK phosphorylation; and (ii) greater TSP-1 expression 
compared to lean counterparts. 
Delimitations 
1. Participants were non-smoking and sedentary between the ages 18 and 35.  Sedentary 
specifies participating in physical activity 3 or fewer times per week for 20 minutes or 
less. One group of individuals were lean with a body mass index (BMI) ≤ 25 kg/m2 while 















CHAPTER 2. METHODS 
The Purdue University Institutional Review Board approved the methods and protocol of 
this study preceding its execution. 
 
2.1 Participant Selection  
 Eight healthy, sedentary, lean (LN) individuals (4 women; 4 men) and eight 
healthy, sedentary, obese (OB) individuals (4 women; 4 men) between the ages of 18-35 
were recruited to participate in this study. Subjects were nonsmoking and had no known 
chronic disease in order to be considered healthy enough to participate. Sedentary 
qualifies as participating in physical activity 3 times or less for 20 minutes or fewer per 
week. Lean individuals had a body mass index (BMI) < 25 kg/m2, while obese 
individuals had a BMI ≥ 30 kg/m2. Qualified individuals were given both verbal and 
written descriptions of the study. Subjects provided signed consent prior to the beginning 
of the study, as well as completed an Activity and Tobacco Questionnaire and a Physical 
Activity Readiness Questionnaire (PAR-Q). Subjects were given instructions on 
completing a three day food intake diary for the days prior to the Day 2 procedures. 








Table 1: Subject Characteristics. Values are listed as Mean ± SE. n = 8 subjects/group. 
  Lean Obese P Value 
Age, yr 21.5 ± 0.5 24.8 ± 1.6 0.09 
Height, cm 169.6 ± 2.9 172.8 ± 3.2 0.48 
Mass, kg 62.4 ± 2.0 109.9 ± 7.8 <0.01 
BMI 21.7 ± 0.8 36.6 ± 1.8 <0.01 
VO2Max , ml O2/kg/min 37.3 ± 2.7 26.1 ± 2.7 0.01 
1 RM, kg 27.8 ± 0.7 40.3 ± 4.7 0.03 
1 RM, kg/kg 0.45 ± 0.01 0.37 ± 0.04 0.17 
Fasting glucose, mM 4.8 ± 0.1 4.9 ± 0.2 0.54 
Fasting insulin, µU/ml 11.8 ± 1.3 28.3 ± 4.8 0.01 
Fasting HOMA-IR 2.46 ± 0.29 6.38 ± 1.23 0.01 
Fasting HDL, mg/dl 58.4 ± 7.3 42.9 ± 5.4 0.08 
Fasting LDL, mg/dl 88.6 ± 12.8 108.6 ± 5.2 0.11 
Fasting Total Cholesterol, mg/dl 162.8 ± 12.3 180.6 ± 7.0 0.17 
Fasting Triglycerides, mg/dl 79.4 ± 7.7 131.6 ± 22.5 0.05 
 
 
2.2 Experimental Design 
 Day 1: Subjects reported to the Max E. Wastl Human Performance Laboratory 
where their height, weight, and dominant leg was recorded prior to the completion of a 
VO2MAX test. Subjects were then given a 15 minute rest period before the completion of a 
one repetition maximum (1 RM) test for single leg, knee extension. 






 Subject VO2MAX was determined two hours post-prandial using a previously 
described incremental protocol (Kraus et al, 2004) on a cycle ergometer (Lode Excalibur 
Sport, Groningen, The Netherlands). A warm up was performed at 50 W for 5 minutes on 
the cycle ergometer. Immediately following, additional workloads were added every 2 
minutes by 25 W until volitional fatigue. Expired air was monitored and recorded via 
open-circuit spirometry (Truemax 2400, Parvo Metrics, Salt Lake City, UT). 
Additionally, heart rate (model H1, Polar Electro, Lake Success, NY) and rate of 
perceived exertion (RPE) was continuously monitored and recorded. Subjects were 
verbally encouraged to continue as long as possible. Criteria for the establishment of 
VO2MAX included 1) a heart rate of at least 90% of age predicted maximum (220-age); 2) 
a respiratory exchange ratio (RER) at or above 1.10; and 3) an identifiable plateau (≤150 
mL increase) in VO2 despite continued increase in workload. At least two of three criteria 
were met for all subjects.   
One Repetition Maximum (1RM) 
 Maximal knee extension was randomized between subjects using either the 
dominant or non-dominant leg. Subjects began in a resting position of 90° and were 
instructed to fully extend their leg undergoing the exercise using a weight of 13.6 kg. 
Once parallel to the floor, they returned to the initial position and were given a rest for 1 
minute. The exercise was repeated with weight increasing by 4.5 kg until the exercised 
leg was no longer able to reach full extension. Once this point was attained, the previous 







Figure 2: Day 2 timeline 
 
 
Day 2: Day 2 occurred at least two weeks after Day 1. This was to avoid any 
influence from the maximal testing incurred on Day 1 on the subjects’ performances on 
Day 2. Three days preceding Day 2, subjects recorded their food intake and partook in a 
12 h fast the night prior. 
Blood draw 
 On the morning of Day 2, subjects reported to the Max E. Wastl Human 
Performance Laboratory where a fasting blood draw was obtained. The 5-8 mL blood 
sample was used for the measurement of glucose, insulin, high density lipoprotein 
(HDL), low density lipoprotein (LDL), triglycerides, and total cholesterol. It was 
collected in a serum tube, allowed for clot formation for 30 minutes at room temperature, 
and then refrigerated until analysis by Mid-America Laboratories. Insulin resistance was 





Fasting serum glucose (FSG) was used in milligrams per deciliter and fasting serum 
insulin (FSI) was used in microunits per millimeter (Matthews et al, 1985). 
Pre- and post-exercise muscle biopsies 














 Immediately following the blood draw, the subjects underwent the procedure to 
obtain the first (PRE) of three muscle biopsies. All biopsies were obtained from the 
vastus lateralis: one biopsy before exercise from the non-working leg and two biopsies 
from the working leg at 15 min post (15 MIN) and 3 h post (3 HR) exercise. The working 
leg was randomized between non-dominant and dominant leg between subjects.  On the 
working leg, the two biopsy sites were separated by at least 3 cm (Costill, Pearson, & 
Fink, 1988). Lidocaine (1%) was used as a local anesthetic to obtain the biopsy samples. 
Tissue samples were immediately placed in liquid nitrogen and stored at -80°C for future 
use. 
Exercise protocol 
Subjects performed three sets of knee extension exercise using their working leg 
immediately following the first biopsy. Workload was set at 80% of their 1RM 
determined on Day 1. 8-12 repetitions were performed for the first two sets and subjects 
were instructed to perform to volitional fatigue for the last set (8-17 repetitions). A two 
minute rest period was allotted between sets. Preliminary analysis found this protocol to 
sufficiently fatigue the subjects and completion did not require any outside assistance. 
Protein Isolation and Western Blot Analysis 
Muscle biopsy samples were frozen in liquid nitrogen and homogenized in RIPA 
buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 0.1% Triton 
X-100, and 0.5% Deoxycholate) with protease inhibitor cocktail and phosphatase 
inhibitor (50 mM NaF and 0.2 mM Na3VO4). Samples were centrifuged at 4°C for 30 
minutes to separate supernatant and insoluble material. The supernatant was used to 






performed in order to investigate angiogenic growth factor expression. Angiogenic 
growth factors include VEGF and VEGF receptor (Gavin et al, 2005); and the anti-
angiogenic (angiostatic) factor include TSP-1 (Olfert et al, 2006). AMPK 
phosphorylation was measured with exercise and obesity as AMPK is an important 
regulator of VEGF (Zwetsloot, Westerkamp, Holmes, & Gavin, 2008).  
Equal amounts of homogenized samples were added to 10% gels. Each membrane 
was loaded with the 3 HR post exercise sample from subject 4 so that membranes could 
be compared to one another. Membranes were then run through electrophoresis in 
running buffer (0.1% SDS, 25 mM Tris, and 190 mM Glycine) at 80 V for 10 minutes, or 
until proteins reached the end of the stacking gel, and then at 100-140 V for 1-2 hours. 
Gels were transferred to PVDF membranes in transfer buffer (190 mM glycine 25 mM 
Tris, and 20% Methanol) for 2 hours at 400 mA. Membranes were stained with Ponceau 
in order to measure total protein loaded in each sample. After imaging, Ponceau was 
rinsed from the membranes and then membranes were blocked with 5% non-fat milk 
dissolved in TBST (25 mM Tris (pH 7.2), 150 mM NaCl, and 0.1% Tween 20) for 1 hour 
at room temperature. Membranes were incubated with primary antibody (VEGF and 
VEGFR2, Santa Cruz; AMPK, p-AMPK, and TSP-1 Cell Signaling Technology) in 5% 
non-fat milk dissolved in TBST at 4°C overnight. Membranes were washed with TBST 
for 10 minutes 3 times and then incubated in anti-rabbit or anti-mouse immunoglobulin 
G-horseradish peroxidase (Cell Signaling Technology) or fluorescence (Li-COR) 
conjugated secondary antibody for 1 hour. Membranes were again washed with TBST for 
10 minutes 3 times and signals were visualized by fluorescence or chemiluminescence 






Quantitative real-time PCR 
 RNA was isolated from muscle tissue samples using Trizol reagent (Invitrogen).  
First-strand cDNA was generated by random hexamer primers with MMLV Reverse 
Transcriptase (Invitrogen). Using a SYBR green PCR kit, the expression level of VEGF, 
VEGFR2, and TSP-1 was determined by real-time PCR reactions in the Roche 
LightCycler® 480 System (Roche). The internal control for gene expression was 18s 
expression. The primer sequences are listed below:  
 
Table 2: Primer sequences for gene expression 
 
Gene Name Forward (5’-3’) Reverse (5’-3’) 
VEGF AGGGCAGAATCATCACGAAGT AGGGTCTCGATTGGATGGCA 
VEGFR2 GTGATCGGAAATGACACTGGAG CATGTTGGTCACTAACAGAAGCA 
TSP-1 AGACTCCGCATCGCAAAGG TCACCACGTTGTTGTCAAGGG 
18s GGCCCTGTAATTGGAATGAGTC CCAAGATCCAACTACGAGCTT 
 
 Statistical Analysis 
 Data were analyzed by use of a two-way (2 groups × 3 time points) mixed-
factorial analysis of variance (ANOVA) test.  Following a significant F ratio, Fisher’s 
LSD post-hoc analysis was performed.  Significance was established at α = 0.05 level and 







CHAPTER 3. RESULTS 
 Subject Characteristics 
 Obese (OB) subjects had significantly greater body mass than lean (LN) subjects 
(OB: 36.6 ± 1.8 kg/m2; LN: 21.7 ± 0.8 kg/m2). LN subjects demonstrated a significantly 
higher VO2Max than OB (LN: 37.3 ± 2.7 ml O2/kg/min; OB: 26.1 ± 2.7 ml O2/kg/min). 
OB demonstrated a higher 1 RM for single leg knee extension (LN: 27.8 ± 0.7 kg; OB: 
40.3 ± 4.7 kg); however, when corrected for body mass, the difference was no longer 
statistically significant (P = 0.17). No differences were observed in fasting glucose 
between groups (LN: 4.8 ± 0.1 mM; OB: 4.9 ± 0.2 mM); however OB demonstrated a 
higher fasting insulin (LN: 11.8 ± 1.3 µU/ml; OB: 28.3 ± 4.8 µU/ml) and fasting HOMA-
IR (LN: 2.46 ± 0.29; OB: 6.38 ± 1.23).  
 
 VEGF and VEGF receptor expression 
 The VEGF mRNA and protein responses to resistance exercise in LN and OB 
subjects are displayed in Figure 3. Exercise significantly increased VEGF mRNA 
similarly at 3 HR in both LN and OB subjects. There was no differences in VEGF protein 










Figure 3. Skeletal muscle vascular endothelial growth factor (VEGF) mRNA (a) protein 
(b) and (c) western blot analysis in response to acute resistance exercise in LN and OB 
individuals. VEGF mRNA was significantly increased at 3 HR. *Significantly different 
from PRE (P ≤ 0.05). Mean ± SE. n = 8 subjects/group. 
 
 Skeletal muscle VEGFR2 mRNA and protein responses to exercise in LN and OB 
individuals are displayed in Figure 4. No differences in the VEGFR2 mRNA or protein 
were found between LN and OB individuals PRE, 15 MIN or 3 HR post exercise. 

























































Figure 4. Skeletal muscle vascular endothelial growth factor receptor (VEGFR2) mRNA 
(a) protein (b) and western blot analysis (c) in response to acute resistance exercise in LN 
and OB individuals. Mean ± SE. n = 8 subjects/group. 
 
 TSP-1 expression 
 Skeletal muscle TSP-1 mRNA and protein responses to exercise in LN and OB 
individuals are displayed in Figure 5. There were no differences in TSP-1 mRNA 
between LN and OB at any time point and no effect of exercise.  Similarly, there was no 






























































Figure 5. Skeletal muscle thrombospondin-1 (TSP-1) mRNA (a) protein (b) and western 
blot analysis (c) in response to acute resistance exercise in LN and OB individuals.  
 
 AMPK and p-AMPK expression 
 Skeletal muscle AMPK and p-AMPK protein responses to exercise in LN and OB 
individuals are displayed in Figure 6. Exercise and obesity had no effect on p-AMPK, 



























































Figure 6. Skeletal muscle 5’ AMP-activated protein kinase (AMPK) protein (a), 
phosphorylated AMPK (p-AMPK) protein (b) p-AMPK/AMPK protein (c) and western 
blot analysis (d) in response to acute resistance exercise in LN and OB individuals. Mean 
























































































CHAPTER 4. DISCUSSION 
 The principal findings of the current study are there were no differences in the 
expression of VEGF, VEGF receptor and TSP-1 at rest and following acute resistance 
exercise between lean and obese groups. Consistent with previous work, resistance 
exercise did increase VEGF mRNA in both lean and obese individuals.  In addition, there 
was no difference at rest or in response to exercise in AMPK between lean and obese 
groups and acute resistance exercise did not increase the phosphorylation of AMPK in 
either group 15 MIN or 3 HR post exercise.   
 
 Obesity and basal VEGF and VEGF receptor expression 
 Similar basal levels of VEGF and VEGF receptor mRNA between the skeletal 
muscle of lean and obese individuals have been previously reported (Gavin et al, 2005). 
No there was no difference in the VEGF and VEGF receptor protein content of the 
skeletal muscle of lean and obese individuals (Gavin et al, 2005). Our data further 
support the notion that VEGF and VEGF receptor mRNA and protein expression are 








 Obesity, exercise and VEGF and VEGF receptor expression 
 The current report utilizes a single bout of resistance exercise, a stimulus of 
muscle hypertrophy when repeated, in order to investigate the reduced capillary density
observed with basal hypertrophy seen in obese individuals. Investigations using animal 
models suggest the skeletal muscle of obese have the ability to hypertrophy but have a 
decreased response to functional overload, a model for resistance exercise, compared to 
lean (Katta et al, 1985; Paturi et al, 2010). Similarly, Donnelly and colleagues showed an 
increased hypertrophy with resistance exercise in obese subjects but did not compare 
these results to lean counterparts (Donnelly et al, 1993). Therefore, this could result in 
lesser angiogenesis in obese individuals compared to lean due to less activation of 
hypertrophic pathways.   
 Very little research regarding the angiogenic response to resistance exercise in 
lean individuals has been conducted. Previous investigations show elevations in VEGF 
mRNA as early as 1 h following the completion of acute resistance exercise in lean 
individuals (Gavin et al 2007; Silvennoinen et al, 2015; Trenerry et al, 2007). Increases in 
VEGF mRNA >2.5 fold have been reported in human subjects (Gavin et al, 2007). This 
is relatively similar to what is shown in the present study, demonstrating an increase of 
~2.2 fold 3 h post exercise. VEGF protein expression did not change following exercise, 
and no differences were found between lean and obese subjects. The present findings are 
in contrast to a previous report of increased VEGF protein expression by ~15% 2 h post 
resistance in lean individuals (Gavin et al, 2007). However, differences in analysis 
techniques could account for the variations, as Gavin and colleagues used ELISA for 






2009). Further investigations are needed in order to develop an accurate time course of 
VEGF protein expression in the skeletal muscle following resistance exercise. 
 Increases in VEGF receptor mRNA have been observed at 4 h but not 2 h post 
resistance exercise in lean individuals (Gavin et al, 2007). Considering other factors 
involved in the present study, 3 h was chosen for the final biopsy with the hopes this 
would be sufficient time for changes in VEGF receptor mRNA to occur. The present 
study shows no increase in VEGF receptor mRNA in lean or obese individuals up to 3 h 
following resistance exercise. Similarly, exercise did not increase skeletal muscle VEGF 
receptor protein expression in lean or obese subjects. Gavin and colleagues also showed 
no changes in VEGF receptor protein expression 4 h post resistance exercise in lean 
individuals, as expected since protein changes occur after mRNA changes (Gavin et al, 
2004). However, VEGF receptor protein expression increases have been observed 6 
hours post aerobic exercise (Gustafsson et al, 2005). Since little is known about other 
factors involved in this study, a 6 h instead of 3 h post biopsy could have resulted in 
potentially missing important changes immediately following the acute resistance 
exercise bout. The last skeletal muscle biopsy was obtained 3 h post exercise in the 
present study. Therefore, 3 h may be insufficient to observe changes in VEGF receptor 
mRNA or protein expression following acute resistance exercise.  
 
 Obesity and basal TSP-1 expression 
 TSP-1 is an angiostatic factor that is present in several tissues and is involved in 
cell adhesion, migration, and growth factor regulation (Lawler, 2002; Roberts, 1996; 






previously been investigated in the adipose tissue, as dynamic alterations in the 
extracellular matrix are required during the expansion of adipose tissue (Kong, Cavalera 
& Frangogiannis, 2014; Sun, Kusminski & Scherer, 2011). Vascularization and adipose 
tissue development are coupled  from early development throughout adult life (Cranell, 
Hausman & Kral, 1997) Adipocytes play an important role in guiding and maintaining 
microvessel growth (Lau, 1990; Lau et al, 1990) and are a major site of TSP-1 secretion 
(Varma et al, 2008). Animal models demonstrate the lack of TSP-1 or its receptors as a 
protective mechanism against the development of obesity (Frazier et al, 2011; Kong et al, 
2013; Maimaitiyiming et al, 2015).  However, it has also been proposed that TSP-1 
deficiency only improves glucose tolerance and increases insulin sensitivity with no 
effect on the development of obesity (Li et al, 2011). TSP-1 mRNA expression in the 
adipose tissue of human subjects suggests a positive correlation between TSP-1 
expressed in the visceral adipose tissue and BMI (Matsuo et al, 2015; Varma et al, 2008). 
Evidence of increased TSP-1 expression in obese is also observed in other organs such as 
the heart (Gonzalez-Quesada et al, 2013) and blood vessels (Stenina et al, 2003). 
 To our knowledge, no previous studies have reported basal levels of TSP-1 
expressed in the skeletal muscle of lean compared to obese individuals. Chronic delivery 
of TSP-1 to the skeletal muscle reduces capillarity, as shown in mouse models (Audet, 
Fulks, Stricker & Olfert, 2013). However, results of the present study show no 
differences in basal skeletal muscle TSP-1 mRNA despite significant differences in BMI. 
Therefore, another angiostatic factor may be responsible for the reduced capillary density 






 Obesity, exercise and TSP-1 expression 
 Investigations of TSP-1 mRNA expression following exercise have been reported 
with lean subjects. In Wistar rats, TSP-1 mRNA expression is increased 3.5 fold 
immediately following aerobic exercise, with further elevations 1 h post exercise before 
returning to baseline (Olfert, Breen, Gavin & Wagner, 2009). Three days of aerobic 
training attenuates this increase while the acute response is restored following 8 wks of 
training (Olfert, Breen, Gavin & Wagner, 2009). TSP-1 mRNA demonstrates a similar 
response to aerobic exercise in lean human subjects (Hoier et al, 2012). The current study 
is the first to investigate the TSP-1 mRNA and protein expression following acute 
resistance exercise in lean and obese subjects.  
Aerobic exercise increases AMPK activity and TSP-1 expression at similar time 
points, within 2 h post exercise (Hoier et al, 2012; Olfert, Breen, Gavin & Wagner, 2009; 
Olfert et al, 2006; Olfert, Wagner, & Power, 2000; Sriwijitkamol et al, 2007; Stephens et 
al, 2002); however the present study shows no increase in AMPK phosphorylation or 
TSP-1 expression following resistance exercise. Though a negative finding, this is 
consistent with TSP-1 expression regulation by AMPK. Further investigation into 
skeletal muscle TSP-1 expression following exercise may be beneficial in order to 
investigate potential regulators of TSP-1 and establish an accurate time course of 
response. 
 
 Obesity and basal p-AMPK and AMPK expression 
 The phosphorylation of AMPK regulates cellular energy usage by increasing the 






energy consuming pathways (Hawley et al, 1995). In obese Zucker rats, basal levels of 
skeletal muscle AMPK phosphorylation and the subsequent p-AMPK:AMPK ratio are 
significantly higher than their lean counterparts (Chen, Lee, Kuo & Ho, 2011). Other 
investigations, including the present study, have found no effect of obesity on basal 
AMPK activity (Lee-Young et al, 2011; Steinberg et al, 2004). Differences between 
human and animal models could in part account for the conflicting results. More 
investigation into the basal activity of AMPK between lean and obese, especially in 
human subjects, is needed. 
 
 Obesity, exercise and p-AMPK and AMPK expression 
 AMPK is an important regulator of the body’s response to stressors. One 
important stressor known to increase AMPK activity is exercise (Winder & Hardie, 
1996). Mouse models have demonstrated that diet-induced obesity has a negative impact 
on AMPK activity in response to acute aerobic exercise (Lee-Young et al, 2011). Similar 
results have been shown in human studies involving moderate intensity aerobic exercise 
in obese subjects (Sriwijitkamol et al, 2007). In contrast, lean and obese Zucker rats show 
no difference in the activation of AMPK following 6 wks of aerobic exercise training 
(Chen, Lee, Kuo & Ho, 2011). However, obese Zucker rats have significantly lower 
AMPK phosphorylation following exercise training, while lean Zucker rats show no 
change (Chen, Lee, Kuo & Ho, 2011). This suggests aerobic exercise training could 
restore the AMPK response of obese subjects.   
 Investigations into AMPK activity in response to resistance exercise in lean 






Dreyer et al, 2006; Silvennoinen et al, 2015). However, the phosphorylation of AMPK 
appears to be resistance exercise volume-dependent. Ahtiainen and colleagues observed 
an increased p-AMPK protein expression 30 min following 10 but not 5 sets of 10 RM 
using a leg press device (Ahtiainen et al, 2015). Previous reports suggest AMPK activity 
is increased within the first 30 min of exercise (Dreyer et al, 2006; Silvennoinen et al, 
2015). The present study observed no changes in p-AMPK following 3 sets of knee 
extension. Therefore, the volume of the current exercise bout may have been insufficient 









 As with all studies, limitations to the experimental design are present in the 
current report. Participants were both male and female and the menstrual cycle of female 
subjects were not controlled for. Hormonal differences could impact the skeletal muscle 
and therefore could result in increases variability within the results. Participants 
documented, but did not alter, their diet in this experiment.  Subjects were asked to eat 
normally and record all food and beverage intake for three days preceding Day 2. Hours 
of sleep prior to Day 2 procedure were not controlled. At least two weeks separated Days 
1 and 2; however the number of days between varied between subjects due to scheduling 
availability. Baseline biopsies were obtained from the non-working leg to avoid three 
biopsies on one single leg. Time of biopsies attempted to capture changes in muscle 
mRNA and proteins with limited information on their time courses following resistance 
exercise. Therefore, potential changes could have been missed. Due to limited 
information on the angiogenic response following resistance exercise, duration and 






 Future Directions  
 The increased VEGF expression reported in the current study further supports 
findings that resistance exercise training can elicit angiogenesis, though there is no 
difference between lean and obese individuals. However, the skeletal muscle of obese 
individuals is unable to maintain capillary density with muscle hypertrophy. It would be 
beneficial to study the long term angiogenic response to high volume resistance training 
in obese individuals, as there appears to be a disruption between the acute response and 
the development of capillaries. Other possible angiostatic factors that could be hindering 







CHAPTER 5. CONCLUSION 
 In summary, the present study demonstrates that lean and obese individuals have 
a similar angiogenic response to acute resistance exercise. Future studies are needed in 
order to observe the effect of repeated bouts of resistance exercise on skeletal muscle 
angiogenesis between lean and obese individuals. Considerations into possible angiostatic 
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